drugset / Trial / NCT00055575

Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies

NCT00055575

Phase 2 Terminated 197 enrolled National Institute of Mental Health (NIMH)
Non-randomizedSequentialQuadruple-blindTreatment

Summary

This study looks at the role of a specific brain chemical system in the mood and attention symptoms seen in major depression and bipolar disorders using functional brain imaging.

Timeline

Start
2003-02-27
Primary completion
2015-02-02
Completion
2015-02-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Scopolamine Unknown Intranasal